دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S1542-3565(23)00920-5
Volume 22, Issue 1, January 2024, Pages A13-A16
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00921-7
Volume 22, Issue 1, January 2024, Pages A17-A19
Adult-Onset Fontan Circuit Failure: A Rare Cause of Protein-Losing Enteropathy
Cheng-Hung Tai, 1,2 Erika Baranowski, 2 Xuchen Zhang, 3 and Darrick K. Li2
doi : 10.1016/j.cgh.2023.07.014
Volume 22, Issue 1, January 2024, Pages A24-A25
Successful Closure of Malignant Esophagorespiratory Fistula in the Upper Esophagus Using a Novel Proximal Release-Type Stent
Tomoya Ueda, 1 Takashi Kanesaka, 1,2 and Hiroshi Miyata
doi : 10.1016/j.cgh.2023.07.024
Volume 22, Issue 1, January 2024, Pages A28-A29
Stepwise Fenestration via Natural Orifice Transluminal Endoscopic Surgery for Symptomatic Polycystic Liver Disease
Dan Liu,* Jiyu Zhang,* and Bingrong Liu
doi : 10.1016/j.cgh.2023.08.043
Volume 22, Issue 1, January 2024, Pages A31-A32
Blue Notes
CHARLES J. KAHI, MD, MS, AGAF
doi : 10.1016/j.cgh.2023.10.003
Volume 22, Issue 1, January 2024, Pages 1-2
Impostor Phenomenon and Microaggressions in Gastroenterology: Exposing the Tip of the Iceberg
doi : 10.1016/j.cgh.2023.10.001
Volume 22, Issue 1, January 2024, Pages 3-8.e1
Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella
Mazen Noureddin, 1,2 Lai Wei, 3 Laurent Castera, 4,5 and Emmanuel A. Tsochatzis
doi : 10.1016/j.cgh.2023.09.034
Volume 22, Issue 1, January 2024, Pages 9-11
Redesigning a Gastroenterology Behavioral Health Program to Improve Patient Access
Jessica K. Salwen-Deremer, 1,2 Shoshana H. Bardach, 3 Lauren K. Tormey, 2 Lauren E. Szkodny, 1 Katherine Gohres, 4 and Corey A. Siegel
doi : 10.1016/j.cgh.2023.09.032
Volume 22, Issue 1, January 2024, Pages 12-15.e1
Learnings From the Graveyard of Phase 2 and 3 Nonalcoholic Steatohepatitis Trials
doi : 10.1016/j.cgh.2023.07.013
Volume 22, Issue 1, January 2024, Pages 16-19
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: True, True, and Related?
KOUSHIK K. DAS
doi : 10.1016/j.cgh.2023.06.027
Volume 22, Issue 1, January 2024, Pages 20-21
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis
David J. Katibian, 1,2 Virginia Solitano, 3,4 D. Brent Polk, 1,2 Tran Nguyen, 3 Christopher Ma, 5,6,7 Gaurav Syal, 8 Taku Kobayashi, 9 Toshifumi Hibi, 9 Sine Buhl, 10 Mark Andrew Ainsworth, 11 Vipul Jairath, 3,7,12 and Siddharth Singh
doi : 10.1016/j.cgh.2023.08.039
Volume 22, Issue 1, January 2024, Pages 22-33.e6
Achalasia is Strongly Associated With Eosinophilic Esophagitis and Other Allergic Disorders
Chanakyaram A. Reddy, 1,2, * Kristina Allen-Brady, 3, * Amiko M. Uchida, 3 Kathryn A. Peterson, 3 Alessandrina M. Hoffman, 3 Rhonda F. Souza, 1,2,§ and Stuart J. Spechler
doi : 10.1016/j.cgh.2023.06.013
Volume 22, Issue 1, January 2024, Pages 34-41.e2
Helicobacter pylori Burden in the United States According to Individual Demographics and Geography: A Nationwide Analysis of the Veterans Healthcare System
Shailja C. Shah, 1,2 Alese E. Halvorson, 3 David Lee, 4 Ranier Bustamante, 5 Brandon McBay, 6 Rohan Gupta, 7 Jason Denton (in memoriam), 8 Chad Dorn, 8 Otis Wilson, 8,9 Richard Peek Jr., 10 Samir Gupta, 1,2 Lin Liu, 5 Adriana Hung, 9,11 Robert Greevy, 3,9 and Christianne L. Roumie
doi : 10.1016/j.cgh.2023.05.016
Volume 22, Issue 1, January 2024, Pages 42-50.e26
The Clinical Impact and Cost-Effectiveness of Surveillance of Incidentally Detected Gastric Intestinal Metaplasia: AÂ Microsimulation Analysis
Nikhil R. Thiruvengadam, 1 Shashank Gupta, 2 Seth Buller, 3 Imad Awad, 2 Devika Gandhi, 1 Allison Ibarra, 4 Gonzalo Latorre, 5 Arnoldo Riquelme, 5,6 Michael L. Kochman,7 Gregory Cote, 8 Shailja C. Shah, 4,9 and Monica Saumoy
doi : 10.1016/j.cgh.2023.05.028
Volume 22, Issue 1, January 2024, Pages 51-61
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk
Kasper A. Overbeek, 1 Brechtje D. M. Koopmann, 1 Iris J. M. Levink, 1 Matteo Tacelli, 2 Nicole S. Erler, 3,4 Paolo Giorgio Arcidiacono, 2 Margreet G. E. Ausems, 5 Anja Wagner, 6 Casper H. van Eijck, 7 Bas Groot Koerkamp, 7 Olivier R. Busch, 8 Marc G. Besselink, 8 Manon van der Vlugt, 9 Lydi M. J. W. van Driel, 1 Paul Fockens,9 Frank P. Vleggaar, 10 Jan-Werner Poley, 1 Gabriele Capurso, 2,11 Djuna L. Cahen, 1 and Marco J. Bruno, 1 on behalf of the Dutch Familial Pancreatic Cancer Surveillance Study work group
doi : 10.1016/j.cgh.2023.03.035
Volume 22, Issue 1, January 2024, Pages 62-71.e7
Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma
Hidenori Toyoda, 1 Mounika Kanneganti, 2 Jonathan Melendez-Torres, 2 Neehar D. Parikh, 3 Prasun K. Jalal, 4 Federico Pi?ero, 5 Manuel Mendizabal, 5 Ezequiel Ridruejo, 6 Hugo Cheinquer, 7 Andrea Casadei-Gardini, 8 Arndt Weinmann, 9 Markus Peck-Radosavljevic, 10 Jean-Francois Dufour,11 Pompilia Radu, 11 Gamal Shiha, 12 Riham Soliman, 13 Shiv K. Sarin, 14 Manoj Kumar, 14 Jing-Houng Wang, 15 Pisit Tangkijvanich, 16 Wattana Sukeepaisarnjaroen, 17 Masanori Atsukawa, 18 Haruki Uojima, 19 Akito Nozaki, 20 Makoto Nakamuta, 21 Koichi Takaguchi, 22 Atsushi Hiraoka, 23 Hiroshi Abe, 24 Kentaro Matsuura, 25 Tsunamasa Watanabe, 26 Noritomo Shimada, 27 Kunihiko Tsuji, 28 Toru Ishikawa, 29 Shigeru Mikami, 30 Ei Itobayashi, 31 Amit G. Singal, 2,§ and Philip J. Johnson
doi : 10.1016/j.cgh.2023.06.026
Volume 22, Issue 1, January 2024, Pages 72-80.e4
Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: AÂ Prospective, Multicenter Study
Daniel Q. Huang, 1,2,3 Noora Ahlholm, 4,5 Panu K. Luukkonen, 4,5 Kimmo Porthan, 4,5 Maral Amangurbanova, 1 Egbert Madamba, 1 Richele Bettencourt, 1 Harris Siddiqi, 1 Vanessa Cervantes, 1 Christie Hernandez, 1 Scarlett J. Lopez, 1 Lisa Richards, 1 Katriina Nemes, 4,6 Helena Isoniemi, 6 Hannele Yki-J?rvinen, 4,5 and Rohit Loomba 1,7,
doi : 10.1016/j.cgh.2023.06.020
Volume 22, Issue 1, January 2024, Pages 81-90.e4
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals
Jagpreet Chhatwal, 1,2,3 Ali Hajjar, 1,4 Peter P. Mueller, 1 Gizem Nemutlu,1,5 Neeti Kulkarni, 1 Mary Linton B. Peters, 1,6 and Fasiha Kanwal
doi : 10.1016/j.cgh.2023.05.024
Volume 22, Issue 1, January 2024, Pages 91-101.e6
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study
Rohit Loomba, 1 Arun J. Sanyal, 2 Atsushi Nakajima, 3 Brent A. Neuschwander-Tetri, 4 Zachary D. Goodman, 5 Stephen A. Harrison, 6 Eric J. Lawitz, 7 Nadege Gunn,8 Kento Imajo, 3 Natarajan Ravendhran, 9 Takemi Akahane, 10 Bradly Boone, 11 Masayuki Yamaguchi, 11 Arkendu Chatterjee, 11 Giridhar S. Tirucherai, 11 Diane E. Shevell, 11 Shuyan Du, 11 Edgar D. Charles, 11 and Manal F. Abdelmalek
doi : 10.1016/j.cgh.2023.04.011
Volume 22, Issue 1, January 2024, Pages 102-112.e9
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study
Manal F. Abdelmalek, 1 Arun J. Sanyal, 2 Atsushi Nakajima, 3 Brent A. Neuschwander-Tetri, 4 Zachary D. Goodman, 5 Eric J. Lawitz, 6 Stephen A. Harrison, 7 Ira M. Jacobson, 8 Kento Imajo, 3 Nadege Gunn,9 Dina Halegoua-DeMarzio, 10 Takemi Akahane, 11 Bradly Boone, 12 Masayuki Yamaguchi, 12 Arkendu Chatterjee, 12 Giridhar S. Tirucherai, 12 Diane E. Shevell, 12 Shuyan Du, 12 Edgar D. Charles, 12 and Rohit Loomba
doi : 10.1016/j.cgh.2023.04.012
Volume 22, Issue 1, January 2024, Pages 113-123.e9
Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study
Quentin M. Anstee, 1 Brent A. Neuschwander-Tetri, 2 Vincent Wai-Sun Wong, 3 Manal F. Abdelmalek, 4 Gerardo Rodriguez-Araujo, 5 Henrik Landgren,5 Grace S. Park, 5 Pierre Bedossa, 6 Naim Alkhouri, 7 Frank Tacke, 8 and Arun J. Sanyal
doi : 10.1016/j.cgh.2023.04.003
Volume 22, Issue 1, January 2024, Pages 124-134.e1
Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases
Daniel Ward, 1 Nynne Nyboe Andersen, 2 Sanne G?rtz, 3 Aske Thorn Iversen, 1 Kristine H?jgaard Allin, 1,4 Laurent Beaugerie, 5 Julien Kirchgesner, 5,§ and Tine Jess
doi : 10.1016/j.cgh.2023.06.025
Volume 22, Issue 1, January 2024, Pages 135-143.e8
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease
Jean-Frédéric Colombel, 1 Bruce E. Sands, 1 Christopher Gasink, 2,10 Benjamin Yeager, 3 Omoniyi J. Adedokun, 4 James Izanec, 2 Tony Ma, 2 Long-Long Gao, 2 Scott D. Lee, 5 Stephan R. Targan, 6 Subrata Ghosh, 7 Stephen B. Hanauer, 8 and William J. Sandborn
doi : 10.1016/j.cgh.2023.06.014
Volume 22, Issue 1, January 2024, Pages 144-153.e2
Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study
Pauline Lemmens,1 Edouard Louis, 2 Wouter Van Moerkercke, 3 Lieven Pouillon, 4 Michael Somers, 5 Harald Peeters, 6 Stijn Vanden Branden, 7 Julie Busschaert, 8 Filip Baert, 9 Anneline Cremer, 10 Philippe Potvin, 11 Sophie Dewit, 12 Arnaud Colard, 13 Jo Swinnen, 14 Guy Lambrecht, 15 Christophe Claessens, 16 Barbara Willandt, 17 Pieter Dewint, 5,18 Evi Van Dyck, 19 Joao Sabino, 1,20 Séverine Vermeire, 1,20 and Marc Ferrante
doi : 10.1016/j.cgh.2023.06.023
Volume 22, Issue 1, January 2024, Pages 154-163.e3
The Association Between a Mediterranean Diet and Symptoms of Irritable Bowel Syndrome
Ellie Y. Chen,1 Swapna Mahurkar-Joshi, 1,2,3 Cathy Liu, 1,2,3 Nancee Jaffe, 1 Jennifer S. Labus, 1,2,3 Tien S. Dong, 1,3 Arpana Gupta, 1,2,3 Shravya Patel, 4 Emeran A. Mayer, 1,2,3 and Lin Chang
doi : 10.1016/j.cgh.2023.07.012
Volume 22, Issue 1, January 2024, Pages 164-172.e6
High-Dimensional Clustering of 4000 Irritable Bowel Syndrome Patients Reveals Seven Distinct Disease Subsets
Anjali Byale, 1 Ryan J. Lennon, 2 Siddharth Byale, 3 Margaret Breen-Lyles, 1 Adam L. Edwinson, 1 Ruchi Gupta, 2 Brian E. Lacy, 4 Janet E. Olson, 2 Lesley A. Houghton, 4,5 and Madhusudan Grover
doi : 10.1016/j.cgh.2022.09.019
Volume 22, Issue 1, January 2024, Pages 173-184.e12
Development of a Computer-aided Prediction Tool for Evaluating Brushing Samples of Biliary Strictures
doi : 10.1016/j.cgh.2023.03.015
Volume 22, Issue 1, January 2024, Pages 185-187.e3
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study
doi : 10.1016/j.cgh.2023.03.017
Volume 22, Issue 1, January 2024, Pages 188-190.e5
Stable Incidence and Risk Factors of Colorectal Cancer in Ulcerative Colitis: A Population-Based Cohort Between 1977–2020
doi : 10.1016/j.cgh.2023.03.022
Volume 22, Issue 1, January 2024, Pages 191-193.e3
Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals
doi : 10.1016/j.cgh.2023.03.031
Volume 22, Issue 1, January 2024, Pages 194-196.e1
NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
doi : 10.1016/j.cgh.2023.05.019
Volume 22, Issue 1, January 2024, Pages 197-199.e3
Exam 1: Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis
doi : 10.1016/j.cgh.2023.10.016
Volume 22, Issue 1, January 2024, Pages e1-e2
Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?
MUNIQUE KURTZ DE MELLONAT?LIA SOUSA FREITAS QUEIROZKONSTANTINOS PAPAMICHAEL
doi : 10.1016/j.cgh.2023.05.007
Volume 22, Issue 1, January 2024, Pages 200-201
Measuring of Postvaccination Hepatitis B Titers in Patients With Inflammatory Bowel Disease: Thoughts for Further Investigation
doi : 10.1016/j.cgh.2023.05.004
Volume 22, Issue 1, January 2024, Pages 201-202
Reply
NAWRAS HABASH IMAD ABASH
doi : 10.1016/j.cgh.2023.05.031
Volume 22, Issue 1, January 2024, Pages 202-203
To Scope or Not to Scope, That is the Question
PHILIPP SCHREINERTHOMAS GREUTER
doi : 10.1016/j.cgh.2023.03.045
Volume 22, Issue 1, January 2024, Pages 203-204
Association of Elevated Liver Enzymes With Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
doi : 10.1016/j.cgh.2023.05.017
Volume 22, Issue 1, January 2024, Pages 204-205
